DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo

Gilead Sciences (NASDAQ: GILD)

104.27 2.78 (2.74%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $104.27 2.74%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $103.44
Previous Close $101.49
Daily Range $101.02 - $104.30
52-Week Range $85.95 - $123.37
Market Cap $153.0B
P/E Ratio 10.67
Dividend (Yield) $1.72 (1.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 11,496,667
Average Daily Volume 11,602,513
Current FY EPS $11.99




Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary

5 Top Stocks to Buy in September

These stocks represent five unique takes on potentially incredible long-term value. Dive in to see how Netflix, Oshkosh, TrueCar, Universal Display, and Gilead Sciences can help you.

AstraZeneca Strikes Deal with Valeant for Psoriasis Drug

Illumina Acquires GenoLogics, Boosts Genomic Sequencing

Meet The Manager Of A Top Performing Mutual Fund

10 Large-Cap Stocks Favored by Big Institutional Investors

Notable ETF Outflow Detected - XLV, GILD, AGN, AMGN

The Market Peak Is In

How To Be Greedy When Others Are Fearful, 5%+ Dividend Yield Portfolio Trades For August 2015

Intercept's (ICPT) OCA Under Priority Review in the U.S.

Amicus (FOLD) Signs Agreement to Acquire Scioderm

See More GILD News...

GILD's Top Competitors

GILD $104.27 (2.74%)
Current stock: GILD
AMGN $152.29 (3.28%)
Current stock: AMGN
CELG $119.60 (3.59%)
Current stock: CELG
$0.00 (0.00%)
Current stock: